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Objective. To assess the incidence of adverse pregnancy outcome in native and nonnative Dutch women with pregestational type
2 diabetes (T2D) in a multicenter study in The Netherlands. Methods. Maternal characteristics and pregnancy outcome were
retrospectively reviewed and the influence of ethnicity on outcome was evaluated using independent 𝑡-test, Mann-Whitney𝑈-test,
and chi-square test. Results. 272 pregnant women (80 native and 192 non-native Dutch) with pregestational T2D were included.
Overall outcome was unfavourable, with a perinatal mortality of 4.8%, major congenital malformations of 6.3%, preeclampsia
of 11%, preterm birth of 19%, birth weight >90th percentile of 32%, and a Caesarean section rate of 42%. In nonnative Dutch
women, the glycemic control was slightly poorer and the gestational age at booking somewhat later as compared to native Dutch
women. However, there were no differences in incidence of preeclampsia/HELLP, preterm birth, perinatal mortality, macrosomia,
and congenital malformations between those two groups. Conclusions. A high incidence of adverse pregnancy outcomes was found
in women with pregestational T2D, although the outcome was comparable between native and non-native Dutch women. This
suggests that easy access to and adequate participation in the local health care systems contribute to these comparable outcomes,
offsetting potential disadvantages in the non-native group.
1. Introduction
Pregestational diabetes mellitus comprises both type 1 and
type2diabetesmellitus.Pregestational type 1 diabetesmellitus
is clearly associated with an increased incidence of adverse
maternal, fetal, and neonatal outcome [1–4], and several
studies in the last two decades have shown that pregestational
type 2 diabetes poses an emerging problem, with pregnancy
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outcomes at least as poor as in women with type 1 diabetes
[5–9]. This gains even more importance in view of the global
diabetes epidemic which leads to ever increasing numbers
of women in the childbearing age with pregestational type 2
diabetes [5, 10]. To add to the problem, pregestational type 2
diabetes is encountered frequently in specific subpopulations
in north-western Europe, such as recently migrated women
from Africa, Asia, and theMiddle East [11].These women are
possiblymore prone to suboptimal participation in the health
care system because of frequently existing language barriers,
generally less financial resources, and low education levels in
those immigrant groups.
The Netherlands can be considered as a representative
developed European country with ethnic minorities reflect-
ing economic and social history [12]. Data from an epidemi-
ological study from the Netherlands revealed that perinatal
mortality is increased in women with a nonnative Dutch
origin [13]. Therefore, the question rises if ethnicity plays
a role in the development of pregnancy complications in
women with type 2 diabetes, since the incidence of type 2
diabetes is more common in specific ethnicities [11]. Unfortu-
nately, the possible relation between ethnicity and pregnancy
complications in women with type 2 diabetes has received
limited attention in western Europe. Data from two British
studies showed no differences in pregnancy outcome between
native British and one single other ethnic (i.e., Afro-Carib-
bean or Indo-Asian) women with type 2 diabetes [14, 15].
However, these studies were not nationwide and compared
no mixture of ethnicities. Therefore, to elucidate more com-
prehensively the potential impact of ethnic origin (and their
possible accompanying problems) on pregnancy outcome, we
performed a retrospective multicentre study to assess mater-
nal, fetal, and neonatal outcome in a large group of native and
a mixture of nonnative Dutch women with pregestational
type 2 diabetes fromdifferent hospitals spread throughout the
Netherlands. We hypothesized that nonnative Dutch women
with type 2 diabetes had a more unfavourable pregnancy
outcome as compared to native Dutch women with type 2
diabetes.
2. Methods
2.1. Patients. A multicentre, retrospective study was per-
formed involving seven large hospitals (University Medical
Centre Groningen, University Medical Centre Utrecht, Aca-
demic Medical Centre Amsterdam, Erasmus Medical Centre
Rotterdam, Medical Centre Haaglanden the Hague, Atrium
Medical Centre Heerlen, and Meander Medical Centre
Amersfoort) spread around theNetherlands. All womenwith
pregestational type 2 diabetes are referred to hospital care in
the Netherlands. 272 women in whom a singleton pregnancy
progressed beyond 20 weeks of gestation and who delivered
between January 1997 and August 2009 were included in an
anonymised database and subsequently evaluated.
The diagnosis pregestational type 2 diabetes was accepted
when patients were anti-GAD antibody negative and/or had
never experienced a keto-acidotic episode and the diabetes
was being managed with diet alone or oral blood glucose-
lowering agents and/or insulin. In the latter case, the diagno-
sis of type 2 diabetes was accepted when treatment with insu-
lin was initiated >6 months after the initial diagnosis.
Patients were divided into native and nonnative Dutch
groups, which was representative for the socioeconomic
history of the Netherlands. Patients in the latter group were
of North-African, Hindu, Afro-Caribbean, Asian, or other
nonnative origin.
2.2. Methods. We retrospectively reviewed all charts and
recordedmaternal characteristics (age, bodymass index, eth-
nic origin, alcohol use, smoking habits, and parity), duration
of diabetes, presence of chronic complications, and precon-
ceptional treatment of diabetes. To assess the potential impact
of ethnicity on pregnancy outcome, the origin of the pregnant
women was classified as (1) native Dutch and (2) nonnative
Dutch. The size of the different ethnic groups (i.e., North-
African, Hindu or Afro-Caribbean, etc.) was too small for
adequate statistical analysis of these specific ethnicities.
HbA1c (mmol/mol) values were recorded andmedianHbA1c
was calculated in the periods one year before pregnancy and
during the first, second, and third trimesters.
2.3. Outcome Measures
2.3.1. Obstetric Complications. Preeclampsia was defined as
a diastolic blood pressure ≥90mmHg on two occasions at
least four hours apart in the second half of pregnancy in
previously normotensive women and de novo albuminuria
(≥300mg/24 h) [16]. In women with preexisting hyperten-
sion, pre-eclampsia was diagnosed when albuminuria de
novo occurred in the second half of pregnancy. HELLP syn-
dromewas defined as platelet count≤100 ⋅ 109/L, elevated liver
enzymes (serum alanine aminotransferase >70U/L and/or
serum aspartate aminotransferase >70U/L), and haemolysis
characterised by serum lactic dehydrogenase level >600U/L
[17]. Preterm birth was defined as delivery before 37 com-
pleted weeks of gestation.
2.3.2. Perinatal Outcome. Only major congenital malforma-
tions, defined as abnormalities that were fatal, requiredmajor
surgery or resulted in severe organ malfunction or cosmetic
defects were recorded and classified as related to the cardio-
vascular, central nervous, urogenital system, or other systems.
Perinatal mortality was defined as fetal loss after 22 weeks of
gestation or neonatal loss during the first 28 days after deliv-
ery. Large for gestational age (LGA) was defined as a birth
weight above the 90th percentile corrected for gestational age,
sex, and parity [18].
2.4. Statistical Analysis. Continuous parameters were
expressed as mean ± SD when normally distributed and as
median (𝑄1–𝑄3) in case of a skewed distribution. Cate-
gorical results were expressed as percentages.The appropriate
(non)parametric tests (i.e., independent 𝑡-test when normally
distributed and Mann-Whitney 𝑈-test in case of a skewed
distribution) were used to compare differences between
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Table 1: General characteristics of the study population. 𝑃 values were calculated between the two ethnic groups.
Maternal characteristics Native Dutch, 𝑛 = 80 % Nonnative Dutch, 𝑛 = 192 % 𝑃
Mean (SD) age in yrs 32.9 ± 4.8 33.1 ± 5.9 0.829
Mean (SD) body mass index in kg/m2 32.1 ± 6.5 30.4 ± 5.6 0.096
Median (𝑄1–𝑄3) GA at 1st booking in weeks 8.0 (6.0–10.3) 11.5 (8.0–19.0) <0.001
Alcohol use 0 0 0 0 n/a
Smoking habits 11 13.8 11 5.7 0.06
Nulliparous 22 27.5 34 17.7 0.079
Median (𝑄1–𝑄3) duration of diabetes (yrs) 2.0 (1.0–5.8) 1.0 (0.0–3.0) 0.004
Chronic complications
Retinopathy 3 3.8 7 3.6 0.657
Neuropathy 1 1.3 2 1.0 0.65
Nephropathy 2 2.5 4 2.1 0.569
Cardiovascular 2 2.5 2 1.0 0.338
Preconceptional treatment of diabetes <0.001
No 22 27.5 80 41.7
Oral 9 11.3 64 30.3
IIT 36 45.0 36 18.8
CSII 6 7.5 1 0.5
Unknown 7 8.8 11 5.7
Glycemic control
Median (𝑄1–𝑄3) HbA1c preconceptional 48 (39–59) (𝑛 = 25)∗ 52 (45–68) (𝑛 = 46)∗ 0.04
Median (𝑄1–𝑄3) HbA1c first trimester 45 (36–57) (𝑛 = 45)∗ 53 (43–66) (𝑛 = 107)∗ 0.001
Median (𝑄1–𝑄3) HbA1c second trimester 37 (34–43) (𝑛 = 47)∗ 45 (40–53) (𝑛 = 118)∗ <0.001
Median (𝑄1–𝑄3) HbA1c third trimester 40 (34–44) (𝑛 = 49)∗ 42 (40–51) (𝑛 = 143)∗ <0.001
Median (𝑄1–𝑄3) HbA1c during pregnancy 41 (36–48) (𝑛 = 49)∗ 48 (41–56) (𝑛 = 143)∗ <0.001
Mean (SD) birth weight in grams 3395 ± 698 3376 ± 822 0.857
∗Number of available HbA1c samples.
groups for continuous data and the chi-square or Fisher’s
exact test for categorical variables. A 𝑃 value <0.05 was con-
sidered as statistically significant. All statistical analyses were
performed using PASW for windows version 18.0 (SPSS, Inc.,
Chicago, IL, USA).
3. Results
A total of 287 singleton pregnancies in women with pregesta-
tional type 2 diabeteswere referred to our centers. 15 pregnan-
cies ended before 20 weeks of gestation, leaving 272 ongoing
pregnancies and deliveries (11 in Amersfoort, 28 in Gronin-
gen, 72 in Utrecht, 65 in Amsterdam, 39 in Rotterdam, 10 in
Heerlen, and 47 in theHague).Data from36women fromone
of the centres have been published before [19].
3.1. Maternal Characteristics. Baseline data of the women are
shown in Table 1. 80 pregnancies (29.4%) were from women
of native Dutch origin and 192 pregnancies were fromwomen
of nonnativeDutch origin (70.6%).The specific origin of non-
native women with pregestational type 2 diabetes was North
African in 73 (26.8%), Hindu in 59 (21.7%), Afro-Caribbean
in 43 (15.8%), Asian in ten (3.7%) and, other nonnative in
seven (2.6%) women.The mean age at conception was 33.0 ±
5.6 (range 18–48 years) and comparable between native and
nonnative Dutch women (32.9 ± 4.8 versus 33.1 ± 5.9; 𝑃 =
0.829). The median gestational age (GA) at first booking was
significantly higher in the nonnative group compared to the
native group (11.5 (8.0–19.0) versus 8.0 (6.0–10.3) weeks; 𝑃 <
0.001). The clinical duration of diabetes was generally short.
There was a significant difference in the use of medication
between the two groups: about half of the native women were
on insulin, whereas about three-quarters of the nonnative
women were on oral glucose-lowering drugs or diet only
at presentation (𝑃 < 0.001). The glycemic control was
less favourable in nonnative women as compared to native
women before and during pregnancy (𝑃 values 0.04 and
<0.001, resp.), although in itself quite reasonable.
3.2. Maternal and Perinatal Outcome. Pregnancy outcome of
the total study population and between native and nonnative
Dutch women is shown in Table 2. In the total study pop-
ulation, median GA at delivery was 38 weeks; no data of
delivery mode was available in one woman because she was
referred to another hospital while in labour. Delivery started
spontaneously in 75 (27.7%) women, labour was induced
in 131 (48.3%), women and a primary Caesarean section
(CS) was performed in 65 (24.0%) women. 49 of the 206
women (23.7%) who were planned to deliver vaginally had
a secondary CS. The total CS rate was 42.1%. The incidence
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Table 2: Maternal and perinatal outcome of the total study population and between native and nonnative Dutch women with pregestational
type 2 diabetes.
Complications DM2 (𝑛 = 272) MV % Native Dutch (𝑛 = 80) MV % Nonnative Dutch (𝑛 = 192) MV % 𝑃 value
Maternal
Preeclampsia/HELLP 29 17 11.4 11 1 13.9 18 6 9.7 0.162
Prematurity 52 0 19.1 16 0 20 36 0 18.8 0.811
Caesarean section 114 1 42.1 44 0 55 70 1 36.6 0.005
Primary 65 1 24.1 29 0 36.3 36 1 18.8 0.007
Secondary 49 1 18.1 15 0 18.8 34 1 17.8 0.797
Perinatal
Perinatal mortality 13 0 4.8 3 0 3.8 10 0 5.2 0.607
Congenital malformations 17 3 6.3 7 1 8.8 10 2 5.3 0.269
Macrosomia 85 6 32.0 24 2 30.8 61 4 32.4 0.789
MV: missing values due to inappropriate data of follow-up.
















birth Cause of death
1∗ Nonnative 65 57 — Cervicalinsufficiency 23 — Prematurity
2∗ Nonnative 54 56 — — 25 AGA Parvo infection
3∗ Nonnative — 45 — — 24 SGA Unexplained
4∗ Nonnative — 78 — — 36 AGA Unexplained
5∗ Nonnative 80 60 Hypoplastic heart — 35 LGA Congenitalmalformation
6† Native — 46 Ventriculomegaly/cerebral anomalies Pre-eclampsia 37 AGA
Congenital
malformation
7† Native — 49 TruncusArteriosus type 2 — 38 AGA
Congenital
malformation
8† Nonnative — — Cardiacmalformation 37 SGA
Congenital
malformation
9† Native 51 46 — Pre-eclampsia 30 AGA Infection
10† Nonnative — 76 — PROM 26 AGA Prematurity
11† Nonnative — — — Chorioamnionitis 22 SGA Prematurity
12† Nonnative — 32 — PROM 33 AGA PROM
13† Nonnative 69 64 — Vacuumextraction 36 LGA Tensionpneumothorax
∗Stillbirth, †neonatal death, PROM: premature rupture of membranes, SGA: small for gestational age (<10th percentile), AGA: appropriate for gestational age,
LGA: large for gestational age (>90th percentile).
of CS was significantly higher in native Dutch women as
compared to nonnative Dutch women. This difference was
caused by a higher incidence of primary CS in native Dutch
women with no difference in the incidence of secondary
CS between the two groups. The other maternal outcome
variables were not different between native and nonnative
Dutch women.
Perinatal Mortality. 13 perinatal deaths (4.8%) occurred in
the total study group, five fetal and eight neonatal deaths
(Table 3). Four (31%) deaths were associated with congenital
malformations; four (31%) infants died before or at a GA of
25 weeks and the remaining five (38%) deaths were due to
infection (𝑛 = 1), premature rupture of the membranes (𝑛 =
2), tension pneumothorax (𝑛 = 1), or remained unexplained
(𝑛 = 1).Nodifferences in perinatalmortality reflectingmater-
nal ethnicity were found.
Congenital Malformations. Major congenital malformations
occurred in 17 (6.3%) infants of the total study population; the
incidence in native and nonnative Dutch women was similar.
Major congenital malformations involved the cardiovascular
system (𝑛 = 7), the central nervous system (𝑛 = 4), urogenital
system anomalies (𝑛 = 2), or other structures (𝑛 = 4). Three
of these women were on oral glucose-lowering drugs during
the first trimester.
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Large for Gestational Age. 85 (31.3%) infants were large for
gestational age in the total study population, with no differ-
ences between native and nonnative Dutch women.
4. Discussion
In contrast to our hypothesis, we showed no differences in
pregnancy outcome between native and nonnative Dutch
women with pregestational type 2 diabetes, with the excep-
tion of a higher CS rate in native Dutch women. However, a
high incidence of adverse pregnancy outcomes in the com-
plete group of women with pregestational type 2 diabetes liv-
ing in the Netherlands was found.
Pregnancy outcome of women with pregestational type 2
diabetes has been studied before and our results are generally
in accordance with those reports [5, 7–9]. According to the
results of a study on ethnic differences in perinatal mor-
tality in the Netherlands [13], we expected that outcome in
nonnative women with type 2 diabetes would be poorer as
compared to native Dutchwomen, for example, linked to cul-
tural or knowledge barriers in some ethnic minorities affect-
ing access to and effectiveness of care. However, we did not
find significant differences in pregnancy outcome (except for
the incidence of CS). These data are in accordance with stud-
ies fromNewZealand and Europe [14, 15, 20, 21]. In the previ-
ous European studies, native Caucasians were compared with
a single other group. In the study of Hughes et al. from New
Zealand, three main ethnicities (i.e., Polynesian, Asian, and
European women) were compared. There are some differ-
ences between these studies and ours. Firstly, we included all
ethnicities, although the limited group size forced us to treat
them statistically as one group. Secondly, none of these stud-
ies were truly nationwide, while the hospitals participating
in our study were spread throughout the Netherlands. From
these studies and from our data, it can be concluded that in a
setting of easy access to and compliance with the local health
care system, outcome in nonnative women with pregesta-
tional type 2 diabetes can be similar to that in native women
with pregestational type 2 diabetes. This easy access to care
might be positively affected by the fact that medical care, for
example, in the Netherlands is fully reimbursed with insur-
ance coverage for basically all inhabitants, resulting in an
absence of any financial barriers to receive medical care.
Apparently, potential negative effects of slightly poorer
glycemic control and later presentation are offset by the care
system.
The only parameter which differed between native and
nonnative Dutch women with pregestational type 2 diabetes
was the higher incidence of a (primary) CS in the native
group. This difference might partly be due to a higher inci-
dence of maternal overweight, which according to US papers
is related to the CS incidence [22, 23]. It may also be that
women of native Dutch origin more often opted and nego-
tiated for a primary CS.
The proportion native/nonnative Dutch (i.e., 29.4% ver-
sus 70.6%) was not representative for the normal Dutch pop-
ulation [24]. Firstly, this can be explained by a higher inci-
dence of type 2 diabetes among specific non-European
subpopulations, such as African, Asian, or Middle-Eastern
populations [11]. Secondly, the hospitals that cooperated to
this study are mainly located in the urban areas of the
Netherlands, where the majority of nonnative Dutch people
are living [25].
Nevertheless, the pregnancy outcome of all studied
women still seems worse than the outcome of the general
population. According to our study, ethnicity appears not to
be involved in the development of this adverse outcome. Pos-
sibly, other factors play a pathophysiological role in this pro-
cess and offer opportunities to improve this adverse outcome.
Firstly, general awareness of the necessity of pregnancy plan-
ning in women with type 2 diabetes may be less than optimal
in The Netherlands, since these women are generally seen in
long-term community care and only referred to secondary
carewhen already pregnant. Unfortunately, wewere unable to
report about the preconceptional care of the studied women,
due to the retrospective nature of our study. Therefore, a
prospective study about the effects of preconceptional care
and pregnancy planning on pregnancy outcome in women
with type 2 diabetes is needed. Secondly, postprandial spikes
of the blood glucose levels contribute to a high-normal
or a minimally elevated, but acceptable (42–53mmol/mol),
HbA1c level [26]. Nowadays, there are novel technical options
to improve the glycemic control, like continuous glucose
monitoring and insulin pumps [1, 27].Thirdly, several studies
indicate that a low socioeconomic status (SES) is associated
with adverse pregnancy outcomes [13, 28, 29]. Since the inci-
dence of type 2 diabetes is the highest in populations with a
low SES [30], an etiological role of this “risk factor” may be
expected in the development of complications during preg-
nancy among women with pregestational type 2 diabetes.
Unfortunately, SES was not sufficiently recorded in our retro-
spective study and SES should, therefore, be analyzed in
future prospective studies.
Limitations of our study are the retrospective nature, the
limited size of the total study population and of the different
ethnic groups, and the possibility of selection bias. Only 272
pregnancies were studied from seven large hospitals covering
a representative area in The Netherlands, but possibly not
fully representative, since four centres are tertiary care centres
and three are larger secondary care centres. This might have
led to a selection bias, since patients with a poor obstetrical
history are referred to tertiary centres.
In conclusion, this study has demonstrated that ethnicity
seems not to be a major issue in the cause of pregnancy com-
plications in women with pregestational type 2 diabetes with
easy access to medical care.The results are still not approach-
ing the pregnancy outcome of healthy, nondiabetic women.
More prospective research is needed to validate these results
and to pay more attention to possible causative factors like
preconceptional care, avoiding postprandial spikes of the
blood glucose and socio-economic status, in the development
of adverse pregnancy outcome in women with pregestational
type 2 diabetes.
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